Figure 1From: Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics Flow diagram for phase 3 study. Reprinted with permission from Kantarjian H, et al. J Clin Oncol 2012 [8].Back to article page